AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Blue Owl Capital, you need to be comfortable with a scaled alternative asset manager that is still trading on a rich earnings multiple, carries meaningful debt and pays out a large dividend that is not well covered by profits or free cash flow. The latest quarter reinforces that tension: revenue continued to grow, but net income slipped versus last year, keeping margins thin while the company affirmed its US$0.23 dividend. At the same time, the €1.6 billion close of OREF Europe and the build out of digital and infrastructure platforms show how fee-earning assets are broadening geographically and by strategy. In the near term, the key catalyst remains whether these newer platforms and existing funds can translate into cleaner, less “one off” earnings, while the biggest risk is that high valuation and leverage leave little room for operational missteps if sentiment turns again after the recent share price rebound.
However, one issue around the sustainability of that generous dividend is worth understanding in detail. Blue Owl Capital's shares are on the way up, but could they be overextended? Uncover how much higher they are than fair value.Explore 8 other fair value estimates on Blue Owl Capital - why the stock might be worth as much as 62% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com